Pharmacological cholesterol lowering reverses fibrotic NASH in obese, diabetic mice with metabolic syndrome

Design and validation of a histological scoring system for nonalcoholic fatty liver disease†

David E. Kleiner, Elizabeth M. Brunt, Mark L. Van Natta et al. · Hepatology · 2005 · 10.5K citations

Nafld Activity Score, Diagnosis, Pathology +24

A lipidomic analysis of nonalcoholic fatty liver disease

Rebecca Baillie, Michelle M. Wiest, Faridoddin Mirshahi et al. · Hepatology · 2007 · 1.3K citations · Full text

Increased Hepatic Synthesis and Dysregulation of Cholesterol Metabolism Is Associated with the Severity of Nonalcoholic Fatty Liver Disease

Hae‐Ki Min, Ashwani Kapoor, Michael Fuchs et al. · Cell Metabolism · 2012 · 635 citations · Full text

Pathology, Fatty Liver Disease, Metabolic Syndrome +17

Mitochondrial free cholesterol loading sensitizes to TNF- and Fas-mediated steatohepatitis

Francisca G. Caballero, Anna Colell, Albert Morales et al. · Cell Metabolism · 2006 · 594 citations · Full text

Lipid Peroxidation, Immunology, Pathology +16

Dietary cholesterol, rather than liver steatosis, leads to hepatic inflammation in hyperlipidemic mouse models of nonalcoholic steatohepatitis†

Kristiaan Wouters, Patrick J. van Gorp, Veerle Bieghs et al. · Hepatology · 2008 · 458 citations · Full text